Clinical Trial Update: Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on autologous bone marrow-derived stem cells for optic neuropathies across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Optic Neuropathy

Drugs mentioned

• Autologous bone marrow-derived stem cells (bone marrow-derived stem cells)

Snippet

Sponsor: Stem Cells Arabia | Conditions: Optic Neuropathy | Phase 1, Phase 2 | Status: UNKNOWN